Product image of Onpattro (Patisiran) 2mg/ml x5ml Vials supplied by GNH India

Onpattro

Active Ingredient:
Patisiran
Form:
Vials
Brand:
Onpattro
Origin:
USA

Onpattro (Patisiran Vials) 2mg/ml x5ml

Onpattro (patisiran) is an injectable medication used to treat hereditary transthyretin-mediated amyloidosis. This rare condition affects nerves and organs. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance.

Strength

2mg/ml x5ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

ALNYLAM PHARMACEUTICALS INC

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Patisiran is prescribed for adults with hereditary transthyretin-mediated amyloidosis, a condition that causes abnormal protein buildup in nerves and organs. It helps reduce symptoms like pain, weakness, and heart problems by targeting the root cause of the disease. This medication is not a cure but may slow progression when used as directed.

Side Effects

  • Patients may experience infusion-related reactions such as flushing, back pain, or nausea during or after administration. Some users report mild fatigue or joint discomfort. These effects are typically temporary and monitored by healthcare professionals. Regular check-ups help assess treatment response and manage any concerns.

Precautions & Warnings

  • Keep vials refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Handle with care to avoid contamination. Inform your doctor about all medications and conditions before starting treatment. Pregnant or breastfeeding individuals should discuss risks with their healthcare provider.

Avoid Interactions

  • Patisiran may interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Avoid alcohol and herbal supplements unless approved by a doctor. Vaccinations should be up to date before starting therapy. Always disclose your full medication list to your healthcare team.

Frequently Asked Questions

Patisiran treats hereditary transthyretin-mediated amyloidosis in adults by reducing abnormal protein buildup.

It is given as an intravenous infusion by a healthcare professional, typically every 3 weeks.

Common effects include infusion reactions like flushing or back pain, and mild fatigue.

No, patisiran must be refrigerated between 2-8°C and protected from light.

Patisiran helps manage symptoms and slow progression but is not a cure for the condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Patisiran

Onpattro

Onpattro

2mg/ml x5ml Vials
Onpattro (patisiran)

Onpattro (patisiran)

2 mg/mL INJECTION, LIPID COMPLEX

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT